Literature DB >> 18769885

Modulation of the activity of newly synthesized human phenylalanine hydroxylase mutant proteins by low-molecular-weight compounds.

Cátia Nascimento1, João Leandro, Isabel Tavares de Almeida, Paula Leandro.   

Abstract

Phenylketonuria, the most frequent disorder of amino acid metabolism, is caused by a deficient activity of human phenylalanine hydroxylase (hPAH). Rescue of the enzyme activity of several recombinant hPAH mutant forms (I65T, R261Q, R270K and V388M) by low molecular weight compounds namely glycerol, trimethylamine N-oxide (TMAO) and sodium 4-phenylbutyrate (4-PB) was investigated using a prokaryotic expression model. The studied compounds were added to the culture medium, in a concentration dependent manner, simultaneously to induction of protein expression. Among the tested molecules glycerol and TMAO were able to increase the enzyme activity of the studied mutant proteins. Furthermore, a decrease in aggregates and a recovery of the active tetrameric and dimeric forms were detected. Since the addition of the studied compounds to the medium did not change the expression level of E. Coli molecular chaperones we postulate that glycerol and TMAO rescue results from a direct stabilizing effect of the newly synthesized mutant hPAH enzymes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18769885     DOI: 10.1007/s10930-008-9149-9

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  30 in total

Review 1.  The osmophobic effect: natural selection of a thermodynamic force in protein folding.

Authors:  D W Bolen; I V Baskakov
Journal:  J Mol Biol       Date:  2001-07-27       Impact factor: 5.469

Review 2.  Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking.

Authors:  David H Perlmutter
Journal:  Pediatr Res       Date:  2002-12       Impact factor: 3.756

3.  Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase.

Authors:  S C Kwok; F D Ledley; A G DiLella; K J Robson; S L Woo
Journal:  Biochemistry       Date:  1985-01-29       Impact factor: 3.162

4.  Expression analysis of phenylketonuria mutations. Effect on folding and stability of the phenylalanine hydroxylase protein.

Authors:  A Gámez; B Pérez; M Ugarte; L R Desviat
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

5.  Substrate-induced conformational transition in human phenylalanine hydroxylase as studied by surface plasmon resonance analyses: the effect of terminal deletions, substrate analogues and phosphorylation.

Authors:  Anne J Stokka; Torgeir Flatmark
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

6.  Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency.

Authors:  J A Burrows; L K Willis; D H Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 7.  Clinical approach to treatable inborn metabolic diseases: an introduction.

Authors:  J-M Saudubray; F Sedel; J H Walter
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

8.  Structure/function relationships in human phenylalanine hydroxylase. Effect of terminal deletions on the oligomerization, activation and cooperativity of substrate binding to the enzyme.

Authors:  P M Knappskog; T Flatmark; J M Aarden; J Haavik; A Martínez
Journal:  Eur J Biochem       Date:  1996-12-15

9.  Chemical chaperones reduce endoplasmic reticulum stress and prevent mutant HFE aggregate formation.

Authors:  Sérgio F de Almeida; Gonçalo Picarote; John V Fleming; Maria Carmo-Fonseca; Jorge E Azevedo; Maria de Sousa
Journal:  J Biol Chem       Date:  2007-07-11       Impact factor: 5.157

10.  Expression of recombinant human phenylalanine hydroxylase as fusion protein in Escherichia coli circumvents proteolytic degradation by host cell proteases. Isolation and characterization of the wild-type enzyme.

Authors:  A Martinez; P M Knappskog; S Olafsdottir; A P Døskeland; H G Eiken; R M Svebak; M Bozzini; J Apold; T Flatmark
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

View more
  7 in total

Review 1.  Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators.

Authors:  Ania C Muntau; João Leandro; Michael Staudigl; Felix Mayer; Søren W Gersting
Journal:  J Inherit Metab Dis       Date:  2014-04-01       Impact factor: 4.982

2.  A new model for allosteric regulation of phenylalanine hydroxylase: implications for disease and therapeutics.

Authors:  Eileen K Jaffe; Linda Stith; Sarah H Lawrence; Mark Andrake; Roland L Dunbrack
Journal:  Arch Biochem Biophys       Date:  2013-01-11       Impact factor: 4.013

3.  Rescue of cystathionine beta-synthase (CBS) mutants with chemical chaperones: purification and characterization of eight CBS mutant enzymes.

Authors:  Tomas Majtan; Lu Liu; John F Carpenter; Jan P Kraus
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

Review 4.  Phenylalanine hydroxylase misfolding and pharmacological chaperones.

Authors:  Jarl Underhaug; Oscar Aubi; Aurora Martinez
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

5.  Chemical chaperones assist intracellular folding to buffer mutational variations.

Authors:  Anannya Bandyopadhyay; Kanika Saxena; Neha Kasturia; Vijit Dalal; Niraj Bhatt; Asher Rajkumar; Shuvadeep Maity; Shantanu Sengupta; Kausik Chakraborty
Journal:  Nat Chem Biol       Date:  2012-01-15       Impact factor: 15.040

6.  Functional characterization and categorization of missense mutations that cause methylmalonyl-CoA mutase (MUT) deficiency.

Authors:  Patrick Forny; D Sean Froese; Terttu Suormala; Wyatt W Yue; Matthias R Baumgartner
Journal:  Hum Mutat       Date:  2014-12       Impact factor: 4.878

7.  Distinct metabolic states of a cell guide alternate fates of mutational buffering through altered proteostasis.

Authors:  Kanika Verma; Kanika Saxena; Rajashekar Donaka; Aseem Chaphalkar; Manish Kumar Rai; Anurag Shukla; Zainab Zaidi; Rohan Dandage; Dhanasekaran Shanmugam; Kausik Chakraborty
Journal:  Nat Commun       Date:  2020-06-10       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.